Micro Interventional Devices, Inc.

Micro Interventional Devices (MID) is the developer of disruptive technologies for use in percutaneous and minimally invasive structural heart repair procedures. MID's proprietary technology is based on a breakthrough in soft- tissue anchoring and associated delivery devices. Its Permaseal device is a novel transapical access device that combines soft -tissue anchors with advanced biocompatible elastomers to provide spontaneous wound closure after structural heart repair procedures, such as transcatheter aortic valve implantation (TAVI). MID acquired Battelle Ventures' portfolio company Endovalve, the developer of a percu-taneous mitral valve replacement technology. General Partner Tracy Warren is a Board director.

Company Web Site
http://microinterventional.com